Thursday, September 8th

PFIZER (Amphitheater)

07h30 - 8h15

Optimal management of patients with acromegaly: practical considerations

7:45-7:50 Opening remarks - Prof. Dr. Philippe Chanson, Université Paris-Saclay, Hôpital Bicêtre, Paris, France

7:50-8:05 Optimizing biochemical control of acromegalic patients: from clinical studies to real life - Prof. Dr. Ilonka Kreitschmann-Andermahr, Klinik für Neurochirurgie und Wirbelsäulenchirurgie Universitätsklinikum, Essen, Germany

8:05-8:20 Challenges of diabetes in acromegaly: a clinical case - Dr. Stefano Frara, Università Vita Salute San Raffaele, Milan, Italy

8:20-8:30 Q&A and closing remarks - All speakers

RECORDATI (Amphitheater)

12h30 - 14h00

12:30–12:35 Welcome and introduction (Mônica Gadelha, MG: Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil)

Cushing’s syndrome clinic

12:35–12:40 Framing the use of medical therapy in Cushing’s syndrome (Rosario Pivonello, RP: Università Federico II di Napoli, Naples, Italy)

12:40–12:45 Canvassing the treatment landscape for Cushing’s syndrome (Antoine Tabarin, AT: University Hospital of Bordeaux, Bordeaux, France)

12:45–13:10 Clinical snapshots: Considerations for practical management of patients with Cushing’s syndrome (Rosario Pivonello and Antoine Tabarin)

Format: Guided case discussion

Acromegaly clinic

13:10–13:15 Framing the use of medical therapy in uncontrolled acromegaly (Diego Ferone, Endocrinology Unit, IRCCS Policlinico San Martino, University of Genova, Italy)

13:15–13:20 Canvassing the treatment landscape for acromegaly (Mônica Gadelha)

13:20–13:45 Clinical snapshots: Considerations for practical management of patients with acromegaly (Mônica Gadelha and Diego Ferone)

13:45–14:00 Q&A and close (All faculty, moderated by Mônica Gadelha)

FRIDAY, September 9th


08h00 - 8h45

Diagnosis of Growth Hormone (GH) disorders: What's new in 2022 ?

Chair: Thierry Brue (France)

IGF-I in the diagnosis of GH disorders. Martin Bidlingmaier (Germany)

Benefits and limitations of dynamic stimulation tests.  Philippe Chanson (France)

IPSEN (Rhône 3)

08h00 - 8h45

Tailored approach to complex patient care: Updates on somatostatin receptor ligands (SRLs)

2mins Welcome and Introduction (Marta Korbonits, Queen Mary, University of London, UK (Chairperson))

8mins Treating patients outside of the hospital: Independent injection vs healthcare-settings (Marta Korbonits)

10mins Exploring the use of extended duration intervals (EDI) in acromegaly (Maria Fleseriu, Oregan Health and Science University, Portland, USA)

10mins Evolving care to meet patient and nurse needs (Sofia Llahana, University of London, UK)

5mins Key takeaways (Marta Korbonits)

10 mins (Q&A, Facilitated by Marta Korbonits)

HRA PHARMA (Rhône 3)

12h30 - 14h00

Managing Cushing’s syndrome through experience: Real-world insights

Chair: Antoine Tabarin

Treating mild hypercortisolism in patients with bilateral macronodular adrenal hyperplasia – Valentina Morelli

Controlling Cushing’s disease in the long-term with medical treatment – Olivier Chabre

New insights into Cushing’s syndrome: The patient’s perspective – Elena Valassi

Q&A session – All speakers

AMRYT (Rhône 2)

12h30 - 14h00

More than Just a Numbers Game: Comprehensive Treatment to Address the Burden of Acromegaly

12:30 : Introduction by Chair : Gérald Raverot (France)

12:35 : An overview of the current treatment paradigm for acromegaly - Marek Bolanowski (Poland)

13:00 : Challenges in the current treatment of acromegaly - Nienke Biermasz (The Netherlands)

13:25 : Improvement beyond biochemical control - Maria Fleseriu (USA)

13:50 : Q&A session